Von Eschenbach Resigning In January With BTC Debate In His Legacy
This article was originally published in The Tan Sheet
Executive Summary
FDA Commissioner Andrew von Eschenbach will return to Texas upon resigning his post Jan. 20, leaving a legacy that includes restarting discussions on whether a third class of drugs is needed